Table 7.
Study | Design | N | Population | Intervention | Primary Endpoint | Outcome |
---|---|---|---|---|---|---|
Nesher et al.37 |
Retrospective | 166 | GCA diagnosed by biopsy or ACR criteria between 1980-2000 |
|
Occurrence of a cranial ischemic complication |
Fewer cranial ischemic complications with aspirin (8% vs 29%; P = .01) |
Lee et al.38 |
Retrospective | 143 | GCA diagnosed by modified ACR criteria between 1989-2004 |
|
Occurrence of an ischemic event; occurrence of bleeding complications |
Fewer ischemic events with aspirin (OR = 0.18; P < .0005) or warfarin (OR = 0.17; P < .04); no observed increase in bleeding complications |
ACR, American College of Rheumatology; GCA, giant cell arteritis; OR, odds ratio.